Maturity Model - Theme 03 Interfaces

Theme 03: Interfaces

An interface is defined as a point of connection between partners of the CCI. Interfaces between themes are the areas in which themes affect each other, have links with each other and where there is a need for an overarching coordination within a CCI. The interfaces are being worked on in the Interface Working Group (IF-WG). Representatives of all participating entities of a CCI and all themes should be represented in the IF-WG. Other stakeholders can also be included.

An Interface Working Group (IF-WG) is established

Level 1

IF111
A first meeting of the Interface Working Group (IF-WG) has taken place.

IF112
Minutes of the meetings with results and measures derived from them are available.

Level 2

IF121
The Interface Working Group (IF-WG) addresses some of the interface topics as listed in this theme.

IF122
The Interface Working Group (IF-WG) includes representatives of at least two themes.

Level 3

IF131
The Interface Working Group (IF-WG) addresses most of the interface topics as listed in this theme.

IF132
The Interface Working Group (IF-WG) includes representatives of at least four themes.

IF133
The Interface Working Group (IF-WG) meets on a regular basis (e.g. at least twice a year for among others updating of the different topics).

Level 4

IF141
The Interface Working Group (IF-WG) addresses all identified interface topics as listed in this theme.

IF142
The Interface Working Group (IF-WG) includes representatives of themes 1-2 and 4-8.

	Level 1	Level 2	Level 3	Level 4
An Interface Working Group (IF-WG) is established	IF111 A first meeting of the Interface Working Group (IF-WG) has taken place. IF112 Minutes of the meetings with results and measures derived from them are available.	IF121 The Interface Working Group (IF-WG) addresses some of the interface topics as listed in this theme. IF122 The Interface Working Group (IF-WG) includes representatives of at least two themes.	IF131 The Interface Working Group (IF-WG) addresses most of the interface topics as listed in this theme. IF132 The Interface Working Group (IF-WG) includes representatives of at least four themes. IF133 The Interface Working Group (IF-WG) meets on a regular basis (e.g. at least twice a year for among others updating of the different topics).	IF141 The Interface Working Group (IF-WG) addresses all identified interface topics as listed in this theme. IF142 The Interface Working Group (IF-WG) includes representatives of themes 1-2 and 4-8.

Level 1

Level 2

Level 3

Level 4

An Interface Working Group (IF-WG) is established

IF111
A first meeting of the Interface Working Group (IF-WG) has taken place.

IF112
Minutes of the meetings with results and measures derived from them are available.

IF121
The Interface Working Group (IF-WG) addresses some of the interface topics as listed in this theme.

IF122
The Interface Working Group (IF-WG) includes representatives of at least two themes.

IF131
The Interface Working Group (IF-WG) addresses most of the interface topics as listed in this theme.

IF132
The Interface Working Group (IF-WG) includes representatives of at least four themes.

IF133
The Interface Working Group (IF-WG) meets on a regular basis (e.g. at least twice a year for among others updating of the different topics).

IF141
The Interface Working Group (IF-WG) addresses all identified interface topics as listed in this theme.

IF142
The Interface Working Group (IF-WG) includes representatives of themes 1-2 and 4-8.

There is a common data infrastructure in the CCI (see theme 1 "Structure of the CCI")

Level 1

IF211
Initial discussions have taken place in the Interface Working Group (IF-WG) regarding the common data infrastructure .

IF212
Initial discussions have taken place regarding the definition of a data utilisation concept .

IF213
Initial discussions have taken place regarding the implementation of standardised data set for data collection within the CCI.

Level 2

IF221
An Interface Working Group (IF-WG) "Data Infrastructure" has been implemented.

IF222
The data utilisation concept is drafted. The draft includes, among other things, coordinated specifications for data definition, collection, storage and analysis, as well as patient consent (e.g. broad consent).

IF223
The data infrastructure is GDPR compliant, and a Quality Management System is in use.

IF224
Sufficient personnel resources are available for the documentation of the data in the networks, study units and CCI's own hospital based cancer registries.

IF225
In some parts of the CCI/for some tumour entities, data are collected on the basis of common, standardised data set.

IF226
The data set correspond to the national/European/international standards/classifications (e.g. ICD-10, ICD-O, WHO, DICOM).

Level 3

IF231
Departments/institutions and persons responsible for the (further) development of the data infrastructure (including legal/ethical aspects) have been appointed.

IF232
The data utilisation concept is in place.

IF233
Data can be exchanged/linked between the CCI networks/institutions (e.g., interfaces, web platforms, etc.) and, if possible, with partners/other registries outside the CCI (cross-border, international).

IF234
Within the CCI, data are collected on the basis of common, standardised data set.

Level 4

IF241
The data utilisation concept is harmonised between different CCIs (national/EU-wide).

IF242
The data infrastructure has interfaces and/or reports data to the population based national cancer registries (if available) or regional cancer registries or screening cancer registries (if participating in screening programmes).

IF243
Study data and data from the biobanks are, if possible, integrated into the data infrastructure.

The CCI has an overall research strategy

Level 1

IF214
Initial discussions have taken place to define the overall research strategy of the CCI, taking into account the existing research strategies that representatives from the themes Structure of the CCI, Comprehensive Cancer Centres (CCCs), Discovery and Translational Research, Clinical Research, Outcomes Research, Screening and Early Detection, and Patient Pathways contributed (if applicable).

Level 2

IF227
An overall research strategy of the CCI is defined and agreed on in the IF-WG.

Level 3

IF235
The overall research strategy includes all relevant research strategy topics .

Level 4

IF244
The overall strategy of the CCI is continuously reviewed and updated with national/regional patient advocacy groups.

The CCI has a strategy for patient involvement and participation

Level 1

IF215
Initial discussions have taken place to define a strategy for patient involvement and participation taking into account the existing concepts that representatives from the theme Structure of the CCI, Comprehensive Cancer Centres (CCCs), Discovery and Translational Research, Clinical Research, Outcomes Research, Screening and Early Detection, and Patient Pathways contributed (if applicable).

Level 2

IF228
A strategy for patient involvement and participation within the CCI is drafted with national/regional patient advocacy groups.

Level 3

IF236
A strategy for patient involvement and participation within the CCI is developed with national/regional patient advocacy groups. This strategy includes all relevant topics.

Level 4

IF245
The research strategy for patient involvement and participation is continuously reviewed and updated with national/regional patient advocacy groups.

The CCI has a continuous educational and training agenda for different disciplines and professional groups within the CCI (see theme 1 "Structure of the CCI")

Level 1

IF216
Initial discussions have taken place to define a continuous educational and training agenda for different disciplines and professional groups within the CCI taking into account the existing education & training agendas.

IF217
There are plans for a programme of seminars, lectures and colloquia between clinicians and researchers.

Level 2

IF229
A continuous educational and training agenda for different disciplines and professional groups within the CCI is drafted, in coordination with national/regional programmes.

IF2210
The agenda takes into account the different areas (research, care, different professional groups) within the CCI and the relevant stakeholder groups (researchers and professional groups that are active in the tumour-specific patient pathways etc.).

IF2211
There is an annual programme of seminars, lectures and colloquia for clinicians and researchers.

Level 3

IF237
A continuous educational and training agenda for different disciplines and professional groups within the CCI is developed, in coordination with national/regional programmes.

IF238
The annual programme of seminars, lectures and colloquia involve clinicians and researchers from inside and outside the CCI.

Level 4

IF246
A continuous educational and training agenda for different disciplines and professional groups within the CCI is developed, in coordination with national/regional programmes, and is continuously reviewed and updated.

IF247
The annual programme of seminars, lectures and colloquia involves conferences with international representation of both clinicians and researchers.

A working group for quality management within the CCI exists

Level 1

IF218
Initial discussions have taken place to define, harmonise and map the QM systems required for the individual areas and processes within the CCI.

Level 2

IF2212
The QM systems required for the individual areas and processes within the CCI are defined, harmonised and mapped.

IF2213
A QM working group within the CCI exists.

Level 3

IF239
The QM working group supports the members or representatives from the themes 1-2 & 4-8 in the implementation and update process of a QM system. E.g., by organising internal audits or training courses on QM-relevant topics.

Level 4

IF248
The QM systems are continuously reviewed and updated.

The CCI promotes the inclusion of outcomes research in the National Cancer Plan (NCP)

Level 3

IF2310
Initial discussions have taken place on how discovery and translational research, clinical research, outcomes research, and screening and early detection can be integrated in the NCP.

Level 4

IF249
The CCI supports the NCP development to well describe discovery and translational research, clinical research, outcomes research, and screening and early detection, including allocation of resources for these research areas and using results from these research areas for further development of the NCP.

	Level 1	Level 2	Level 3	Level 4
There is a common data infrastructure in the CCI (see theme 1 "Structure of the CCI")	IF211 Initial discussions have taken place in the Interface Working Group (IF-WG) regarding the common data infrastructure . IF212 Initial discussions have taken place regarding the definition of a data utilisation concept . IF213 Initial discussions have taken place regarding the implementation of standardised data set for data collection within the CCI.	IF221 An Interface Working Group (IF-WG) "Data Infrastructure" has been implemented. IF222 The data utilisation concept is drafted. The draft includes, among other things, coordinated specifications for data definition, collection, storage and analysis, as well as patient consent (e.g. broad consent). IF223 The data infrastructure is GDPR compliant, and a Quality Management System is in use. IF224 Sufficient personnel resources are available for the documentation of the data in the networks, study units and CCI's own hospital based cancer registries. IF225 In some parts of the CCI/for some tumour entities, data are collected on the basis of common, standardised data set. IF226 The data set correspond to the national/European/international standards/classifications (e.g. ICD-10, ICD-O, WHO, DICOM).	IF231 Departments/institutions and persons responsible for the (further) development of the data infrastructure (including legal/ethical aspects) have been appointed. IF232 The data utilisation concept is in place. IF233 Data can be exchanged/linked between the CCI networks/institutions (e.g., interfaces, web platforms, etc.) and, if possible, with partners/other registries outside the CCI (cross-border, international). IF234 Within the CCI, data are collected on the basis of common, standardised data set.	IF241 The data utilisation concept is harmonised between different CCIs (national/EU-wide). IF242 The data infrastructure has interfaces and/or reports data to the population based national cancer registries (if available) or regional cancer registries or screening cancer registries (if participating in screening programmes). IF243 Study data and data from the biobanks are, if possible, integrated into the data infrastructure.
The CCI has an overall research strategy	IF214 Initial discussions have taken place to define the overall research strategy of the CCI, taking into account the existing research strategies that representatives from the themes Structure of the CCI, Comprehensive Cancer Centres (CCCs), Discovery and Translational Research, Clinical Research, Outcomes Research, Screening and Early Detection, and Patient Pathways contributed (if applicable).	IF227 An overall research strategy of the CCI is defined and agreed on in the IF-WG.	IF235 The overall research strategy includes all relevant research strategy topics .	IF244 The overall strategy of the CCI is continuously reviewed and updated with national/regional patient advocacy groups.
The CCI has a strategy for patient involvement and participation	IF215 Initial discussions have taken place to define a strategy for patient involvement and participation taking into account the existing concepts that representatives from the theme Structure of the CCI, Comprehensive Cancer Centres (CCCs), Discovery and Translational Research, Clinical Research, Outcomes Research, Screening and Early Detection, and Patient Pathways contributed (if applicable).	IF228 A strategy for patient involvement and participation within the CCI is drafted with national/regional patient advocacy groups.	IF236 A strategy for patient involvement and participation within the CCI is developed with national/regional patient advocacy groups. This strategy includes all relevant topics.	IF245 The research strategy for patient involvement and participation is continuously reviewed and updated with national/regional patient advocacy groups.
The CCI has a continuous educational and training agenda for different disciplines and professional groups within the CCI (see theme 1 "Structure of the CCI")	IF216 Initial discussions have taken place to define a continuous educational and training agenda for different disciplines and professional groups within the CCI taking into account the existing education & training agendas. IF217 There are plans for a programme of seminars, lectures and colloquia between clinicians and researchers.	IF229 A continuous educational and training agenda for different disciplines and professional groups within the CCI is drafted, in coordination with national/regional programmes. IF2210 The agenda takes into account the different areas (research, care, different professional groups) within the CCI and the relevant stakeholder groups (researchers and professional groups that are active in the tumour-specific patient pathways etc.). IF2211 There is an annual programme of seminars, lectures and colloquia for clinicians and researchers.	IF237 A continuous educational and training agenda for different disciplines and professional groups within the CCI is developed, in coordination with national/regional programmes. IF238 The annual programme of seminars, lectures and colloquia involve clinicians and researchers from inside and outside the CCI.	IF246 A continuous educational and training agenda for different disciplines and professional groups within the CCI is developed, in coordination with national/regional programmes, and is continuously reviewed and updated. IF247 The annual programme of seminars, lectures and colloquia involves conferences with international representation of both clinicians and researchers.
A working group for quality management within the CCI exists	IF218 Initial discussions have taken place to define, harmonise and map the QM systems required for the individual areas and processes within the CCI.	IF2212 The QM systems required for the individual areas and processes within the CCI are defined, harmonised and mapped. IF2213 A QM working group within the CCI exists.	IF239 The QM working group supports the members or representatives from the themes 1-2 & 4-8 in the implementation and update process of a QM system. E.g., by organising internal audits or training courses on QM-relevant topics.	IF248 The QM systems are continuously reviewed and updated.
The CCI promotes the inclusion of outcomes research in the National Cancer Plan (NCP)			IF2310 Initial discussions have taken place on how discovery and translational research, clinical research, outcomes research, and screening and early detection can be integrated in the NCP.	IF249 The CCI supports the NCP development to well describe discovery and translational research, clinical research, outcomes research, and screening and early detection, including allocation of resources for these research areas and using results from these research areas for further development of the NCP.

Theme 03: Interfaces

Interface Platform

Interface Topics